
Parcell Laboratories
Parcell Laboratories: Innovating regenerative medicine with unique adult stem cell therapies since 2008.

Parcell Laboratories: Innovating regenerative medicine with unique adult stem cell therapies since 2008.
Parcell Laboratories, founded in 2008, is dedicated to advancing regenerative medicine through its unique adult stem cell platform technology, the ELA® cell. Discovered by scientists affiliated with Brigham and Women’s Hospital and Harvard Medical School, ELA cells are distinguished by a specific surface marker profile and are found in various tissues throughout the body. The company's mission is to develop novel therapeutics leveraging these cells to address a range of medical conditions.
Notable individuals associated with Parcell Laboratories include researchers from prestigious institutions like Harvard Medical School. The company has attracted significant interest from investors focused on cutting-edge medical technologies. Key achievements include demonstrating the vast potential of ELA cells in regenerative medicine, positioning Parcell Laboratories as a leader in the field. Their innovative approach has had a considerable impact on the development of new treatments, contributing to advancements in healthcare and offering hope for patients with previously untreatable conditions.
Companies similar to Parcell Laboratories include LaCell, APstem Therapeutics, Personalized Stem Cells and Stemgenics.
Parcell Laboratories was founded in 2008.
Parcell Laboratories' headquarters is located in Natick, MA, US.
Parcell Laboratories' most recent funding round was for $500k (USD) in May 2014.
As of May 16, 2014, Parcell Laboratories has disclosed funding of $500k (USD). Undisclosed round amounts are excluded.
Stemgenics
stemgenics.com